Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty

NCT07138898 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT07138898
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07138898 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
Lead sponsor
NYU Langone Health
Phase
Phase 2
Overall status
Recruiting
Start date
December 12, 2025
Completion date
January 31, 2028
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatic disease